首页> 外国专利> Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising the derivative, and use thereof

Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising the derivative, and use thereof

机译:新型八氢噻吩并喹啉衍生物,包含该衍生物的药物组合物及其用途

摘要

A compound represented by the general formula (I): ** Formula ** or a pharmaceutically acceptable salt thereof, wherein R1 is any one of the following a) to d): a) a cyano group, b) a carbamoyl group, c) a C2-C7 alkoxycarbonyl group, or d) a carboxy group; R2 and R3 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C7 acyl group, or a (C2-C7) alkoxy carbonyl group; R4 is a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group; R5 is any one of the following a) to j): a) a C1-C6 alkyl group, b) a C1-C6 haloalkyl group, c) a cycloalkyl group, d) a benzofused cycloalkyl group, e) a C1- cycloalkylalkyl group C6, f) an aralkyl group, wherein the ring of the aralkyl group is unsubstituted or substituted with 1 to 5 substituents selected independently from the group consisting of a halogen atom, a C1-C6 alkyl group, a C1- haloalkyl group C6, a C1-C6 alkoxy group, and a C1-C6 hydroxyalkyl group, g) a C1-C6 heteroarylalkyl group, wherein the ring of the C1-C6 heteroarylalkyl group is unsubstituted or substituted with 1 to 3 substituents selected independently of the group consisting of a C1-C6 alkyl group, a C1-C6 haloalkyl group, and a C1-C6 alkoxy group, h) a C2-C6 alkenyl group, i) a C1-C6 alkoxy group C1-C6, or j) a R10R11N-C1-C6 alkyl group; R6 and R7 are each independently any one of the following a) to k): a) a hydrogen atom, b) a C1-C6 alkyl group, c) a C1-C6 haloalkyl group, d) a heterocycloalkyl group, e) a C1-C6 heterocycloalkylalkyl group, f) an aralkyl group, wherein the ring of the aralkyl group is unsubstituted or substituted with 1 to 5 substituents selected independently from the group consisting of a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, and a R10R11N-C1-C6 alkyl group, g) a C1-C6 heteroarylalkyl group, wherein the ring of the C1-C6 heteroarylalkyl group is unsubstituted or substituted by 1 to 3 substituents independently selected from the group consisting of a C1-C6 alkyl group, a C1-C6 haloalkyl group, and a C1-C6 alkoxy group, h) a C1-C6 alkoxy group, C1-C6 alkyl,
机译:由通式(I)表示的化合物:** **或其药学上可接受的盐,其中R 1为以下a)至d)中的任何一个:a)氰基,b)氨基甲酰基,c )C2-C7烷氧羰基,或d)羧基; R 2和R 3各自独立地为氢原子,C 1 -C 6烷基,C 1 -C 7酰基或(C 2 -C 7)烷氧基羰基; R4是氢原子,碳数1〜6的烷基或碳数1〜6的卤代烷基。 R5是以下a)至j)中的任何一个:a)C1-C6烷基,b)C1-C6卤代烷基,c)环烷基,d)苯并稠合的环烷基,e)C1-环烷基烷基基团C6,f)是芳烷基,其中芳烷基的环是未取代的或被1-5个独立地选自卤素原子,C1-C6烷基,C1-卤代烷基C6的取代基取代, C 1 -C 6烷氧基和C 1 -C 6羟烷基,g)C 1 -C 6杂芳基烷基,其中C 1 -C 6杂芳基烷基的环是未取代的或被1-3个独立于以下基团的取代基取代的: C 1 -C 6烷基,C 1 -C 6卤代烷基和C 1 -C 6烷氧基,h)C 2 -C 6烯基,i)C 1 -C 6烷氧基C 1 -C 6,或j)R 10 R 11 N-C1 -C6烷基; R6和R7各自独立地是以下a)至k)中的任何一个:a)氢原子,b)C1-C6烷基,c)C1-C6卤代烷基,d)杂环烷基,e)a C 1 -C 6杂环烷基烷基,f)芳烷基,其中芳烷基的环是未取代的或被1-5个独立地选自卤素原子,C 1 -C 6烷基,C 1 -C 6的取代基取代卤代烷基,C 1 -C 6烷氧基和R 10 R 11 N-C 1 -C 6烷基,g)C 1 -C 6杂芳基烷基,其中C 1 -C 6杂芳基烷基的环未被取代或被1-3个独立选择的取代基取代选自C 1 -C 6烷基,C 1 -C 6卤代烷基和C 1 -C 6烷氧基,h)C 1 -C 6烷氧基,C 1 -C 6烷基,

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号